Clinical Trials Logo

Clinical Trial Summary

The scar site was divided into 3 sites; combined IPL/fractional Er:YAG laser treatment site, fractional Er:YAG laser treatment site and untreated control site. At baseline, three lesions were randomized to IPL / fractional Er:YAG laser combination therapy site, fractional Er:YAG laser treatment alone site, and untreated control site. The laser treatment was conducted total three sessions, immediately at suture removal (baseline), 4 weeks after suture removal and 8 weeks after suture removal. The evaluation of scar site was conducted 3 months later after last treatment (20 weeks after suture removal).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04722705
Study type Interventional
Source Hallym University Kangnam Sacred Heart Hospital
Contact Bo Young Chung, M.D., PhD
Phone +82-10-8940-4343
Email victoryby@naver.com
Status Recruiting
Phase N/A
Start date January 6, 2020
Completion date November 14, 2021

See also
  Status Clinical Trial Phase
Completed NCT00892723 - A Study to Evaluate the Safety and Efficacy of Additional Doses of AZX100 Drug Product Following Excision of Keloid Scars Phase 2
Active, not recruiting NCT06312527 - Mepiform in Simultaneous Bilateral TKA N/A
Completed NCT00825916 - A Study to Evaluate the Safety and Efficacy of AZX100 Drug Product Following Excision of Keloid Scars Phase 2
Completed NCT01640912 - Evaluation of the Safety, Pharmacokinetics, and Preliminary Effect on Scar Formation by RXI-109 Phase 1
Completed NCT04707131 - A Study of Single Ascending Dose of LEM-S401 in Healthy Participants Phase 1
Terminated NCT01826942 - Scar Prevention Using Fractional Carbon Dioxide Laser Treatment N/A
Completed NCT00811577 - A Phase 2a Study to Evaluate the Safety and Efficacy of AZX100 in Trocar Sites of Arthroscopic Shoulder Surgery Patients Phase 2
Completed NCT01037985 - Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty Phase 2
Completed NCT01037413 - Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery Phase 2
Completed NCT01780077 - Evaluation of Safety, PK, and Preliminary Effects on Scar Formation of Multiple Intradermal Administrations of RXI-109 Phase 1
Completed NCT01038297 - Safety and Efficacy Study of Different Dose Levels of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty Phase 2